Antiphospholipid Syndrome Collaborative Registry (APSCORE)

Completed

Conditions studied: Antiphospholipid Syndrome

In brief

Antiphospholipid Syndrome (APS) is an autoimmune disorder in which the body recognizes certain normal components of blood and/or cell membranes as foreign substances and produces antibodies against them. Patients with these antibodies may experience miscarriages and blood clotting disorders, including heart attacks and strokes. APS may occur in people with systemic lupus erythematosus and other autoimmune diseases, or in otherwise healthy individuals. The Antiphospholipid Syndrome Collaborative Registry (APSCORE) is a national registry and tissue repository for patients with APS. This registry will collect clinical information and blood samples from people with APS.

Key facts

Study ID

NCT00076713

Run by

University of North Carolina, Chapel Hill

People needed

860

Starts

2000-04-01

Expected to finish

2007-04-01

Last updated by the study team

2013-02-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Antiphospholipid antibodies with or without associated clinical manifestations

Where it is running

• Morehouse School of Medicine — Atlanta, Georgia, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• Hospital for Special Surgery, Weill-Cornell University Medical Center — New York, New York, United States
• University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
• Duke University Medical Center — Durham, North Carolina, United States
• University of Texas Health Science Center — San Antonio, Texas, United States
• University of Utah Health Science Center — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.